Design and biological activity of β-sheet breaker peptide conjugates
- 6 March 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 380 (2), 397-401
- https://doi.org/10.1016/j.bbrc.2009.01.090
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Inhibition of Protein Misfolding and Aggregation by Small Rationally-Designed PeptidesCurrent Pharmaceutical Design, 2006
- Polymer Therapeutics: Concepts and ApplicationsAngewandte Chemie International Edition, 2006
- Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term PotentiationJournal of Neuroscience, 2005
- Pharmacological Profiles of Peptide Drug Candidates for the Treatment of Alzheimer's DiseaseJournal of Biological Chemistry, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Converting a Peptide into a Drug: Strategies to Improve Stability and BioavailabilityCurrent Medicinal Chemistry, 2002
- Inhibition of Alzheimer's Amyloidosis by Peptides That Prevent β-Sheet ConformationBiochemical and Biophysical Research Communications, 1996
- The α-Helical to β-Strand Transition in the Amino-terminal Fragment of the Amyloid β-Peptide Modulates Amyloid FormationJournal of Biological Chemistry, 1995
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992